Curevo Vaccine logo
VerifiedBiotechnology Research· Founded 2017

Curevo Vaccine

Curevo Vaccine is a clinical-stage developer of vaccines for varicella and herpes zoster. Amezosvatein (CRV-101) is an adjuvanted subunit (non-mRNA) vaccine designed to prevent herpes zoster, commonly known as shingles. Our goal with a new herpes zoster vaccine is to improve the patient experience and, ultimately, overall vaccination rates, by developing amezosvatein as a vaccine with non-inferior efficacy combined with clinically-meaningful improvements in reactogenicity when compared to Shingrix.

7-day free trial · no credit card

HeadquartersBothell, United StatesEmployees45(11 to 50)Founded year2017Websitecurevovaccine.comLinkedIn profileLinkedIn

Verified contacts

36

available on Kipplo

LinkedIn employees

45

11 to 50 range

Open roles

no listings

Distinct roles

28

indexed titles

Tech stack

1

tools in use

Monthly traffic

49

organic / mo

Sign up free to see all 36 verified contacts at Curevo Vaccine

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Decision-makers and verified team members

36 contacts with verified email or phone · masked until revealed.

Sign up free →

Top roles at Curevo Vaccine

28 distinct titles indexed · top 10 shown.

  • 3program manager
  • 2senior director of regulatory affairs
  • 1()
  • 1, 2 ()
  • 1associate director of quality cmc
  • 1associate director, clinical quality
  • 1associate director, cmc regulatory affairs
  • 1associate director, product development
  • 1ceo
  • 1clinical trial associate
  • +18more titles

Sign up to unlock all 36 contacts at Curevo Vaccine

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Sign up to reveal 36 verified contacts at Curevo Vaccine

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.

Curevo Vaccine | Kipplo Discover